Qiagen

Qiagen Obtains CE Mark for Molecular HSV Test on NeuMoDx Platforms

In Brief This Week: Qiagen, Renalytix, OpGen, PerkinElmer, Avacta, Paige, More

Wi-Fi Connectivity IP Lawsuit Against Qiagen Dismissed by Plaintiff

Qiagen Q4 Revenues Grow 2 Percent as Firm Beats Estimates, Guidance

Qiagen Next-Gen QuantiFeron Tuberculosis Test Gains Chinese Regulatory Approval

JP Morgan Healthcare Conference Day 1: Qiagen, Adaptive Bio, Guardant Health, Natera, Sema4

In Brief This Week: Qiagen, Cue Health, Co-Diagnostics, Vela Diagnostics, and More

Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment

Qiagen Obtains CE Mark for Assay Measuring T-Cell Response to SARS-CoV-2

Qiagen Sued for Allegedly Infringing Patent With Wi-Fi-Connected Instrument

Qiagen, DiaSorin Obtain FDA Approval for Latent TB Test on Benchtop Platform

Qiagen Settles Becton Dickinson Patent Infringement Lawsuit for $53M

Qiagen Reports 11 Percent Q3 Revenue Growth; Raises Full-Year Guidance

Qiagen Gets CE Mark for Molecular Multiplex Respiratory Pathogen Assay

Qiagen, NeuMoDx Lose Patent Appeal in BD/HandyLab Dispute

Qiagen Obtains CE Mark for Point-of-Care Tuberculosis Infection Test

Qiagen Wins $3.4M US DOD Contract for COVID-19 PCR Test Production

In Brief This Week: Qiagen, Ortho Clinical Diagnostics, MicroGen Diagnostics, and More